Comparing two anaesthetic drugs named Propofol and Remifentanil for endoscopic diagnostic procedure involving lungs

Comparision of Remifentanil and Dexmedetomidine in combination with Propofol for Anaesthesia during Flexible Bronchoscopy - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088419

Enrollment

Registered

2025-06-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J40- Bronchitis, not specified as acuteor chronic

Interventions

Intervention1: Remifentanil and Propofol: Injection REMIFENTANIL 0.2 mcg/kg will be started 5 minutes prior to the procedure and Propofol 0.5 mg/kg will be decided on table based on requirement Interv

Eligibility

Inclusion criteria

Inclusion criteria: ASA classification 1 to 3 Age 18 to 70 years

Exclusion criteria

Exclusion criteria: Pregnancy

Design outcomes

Primary

Measure	Time frame
Sedation PropertyTimepoint: Zero minutes to recovery	—

Secondary

Measure	Time frame
Incidence of cough Introprocedure requirement of topical Anaesthesia Bronchocopist satisfaction Recovery time Timepoint: Zero minutes to recovery	—

Countries

India

Contacts

Public ContactUma P K

SKS Hospital and Postgraduate Training Institute

sathyaprakash.m@sksh.ac.in9524659719

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026